Harmony Biosciences Holdings, Inc.
HRMYDrugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
2
Next Catalyst
Jan 18, 2027
21wMarket Overview
Stock performance and key metrics
3 upcoming, 1 past
Harmony Reports Financial Results
Filed: 2026-05-07 AccNo: 0001104659-26-056786 Size: 5 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Beat Q2 earnings and revenue estimates
Source2 more catalysts beyond 14 days
Start a 48-hour free trial to see all upcoming catalysts
How HRMY's past catalysts played out
No drugs found in this phase.
Full breakdown — the signals behind the verdict
Frequently asked questions
When is Harmony Biosciences Holdings, Inc.'s next FDA catalyst?→
Harmony Biosciences Holdings, Inc.'s (HRMY) next tracked catalyst is a PDUFA expected January 18, 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track HRMY biotech catalysts?→
Add HRMY to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Harmony Biosciences Holdings, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.